{
  "trial_id": "NCT01848743",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "HBsAg (+) > 6 months",
      "label": "met",
      "evidence": "positive"
    },
    {
      "criterion": "ALT > 5X ULN",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Prolongation of prothrombin time > 3 seconds and bilirubin level > 2 mg/dl",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "20-75 years old",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "HAV, HCV, HDV and HIV co-infection",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Concurrent hepatocellular carcinoma",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Drug, metabolic or alcohol as cause of hepatitis",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Anti-viral treatment in recent 6 mnths",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has chronic HCV infection and is on combination therapy with IFN and RBV. Direct antiviral drugs were added to his treatment 6 months ago.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT01848743",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}